From Pain Points to Solutions - ViVE and CHIME Shift from Hype to Hope in Transforming the Health System

A worrying number of patients with an initially mild infection of Covid are developing long term conditions and symptoms that require medical attention. CDC suggest up 68 percent of us.

Monoclonal antibodies were first used in humans in the 1980s². They have gradually become more prevalent with Regeneron, producing and selling this treatment for those with severe COVID-19

HHS has just released the "COVID Community Profile Report," a daily updated snapshot of how COVID-19 is affecting our states and communities